GPT Ebitda from 2010 to 2024

GPTHEALTH   177.05  4.07  2.35%   
GPT Healthcare EBITDA yearly trend continues to be quite stable with very little volatility. The value of EBITDA is projected to decrease to about 745.8 M. From the period between 2010 and 2024, GPT Healthcare, EBITDA regression line of its data series had standard deviation of  254,254,551 and standard deviation of  254,254,551. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
1.1 B
Current Value
745.8 M
Quarterly Volatility
254.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check GPT Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GPT Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 152.2 M, Selling General Administrative of 39 M or Selling And Marketing Expenses of 29.9 M, as well as many indicators such as . GPT financial statements analysis is a perfect complement when working with GPT Healthcare Valuation or Volatility modules.
  
This module can also supplement various GPT Healthcare Technical models . Check out the analysis of GPT Healthcare Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in GPT Stock

GPT Healthcare financial ratios help investors to determine whether GPT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GPT with respect to the benefits of owning GPT Healthcare security.